[IKT] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
16-Oct-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 7.30%
YoY- 17.35%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 80 116 65 123 0 7 46 44.56%
PBT -4,595 -5,778 -4,478 -4,279 -4,495 -4,640 -4,641 -0.66%
Tax 46 37 -474 -112 0 -4,640 -4,641 -
NP -4,595 -5,778 -4,003 -4,167 -4,495 -4,640 -4,641 -0.66%
Tax Rate - - - - - - - -
Total Cost 4,675 5,894 4,068 4,291 4,495 4,646 4,687 -0.17%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -5,775.11 -4,963.46 -6,204.86 -3,375.91 0.00 -70,817.14 -10,081.47 -31.00%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.86 -1.11 -0.87 -0.99 -1.06 -1.10 -1.10 -15.12%
EPS Diluted -0.86 -1.11 -0.87 -0.99 -1.06 -1.10 -1.10 -15.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.